Are pathological high-risk features in locally advanced rectal cancer a useful selection tool for adjuvant chemotherapy?

We confirmed that several stage-independent biomarkers were significantly associated with a decreased outcome in rectal cancer patients. More importantly, these markers did not have predictive value and are thus not useful to select for adjuvant therapy in rectal cancer.